Gout: no longer the disease of kings

Michael E Zychowicz1

  • 1Duke University School of Nursing, Durham, NC, USA.

Orthopedic Nursing
|September 22, 2011
PubMed

Insights

Gout incidence is increasing, particularly in the elderly, with risk factors including hyperuricemia, hypertension, and certain dietary choices. This condition can lead to severe joint and organ damage over time.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Epidemiology

Background:

  • Gout, historically termed the "disease of kings," now exhibits significantly increased incidence and prevalence.
  • The rising incidence of gout is particularly notable in the elderly population.
  • Associated risk factors for gout include hyperuricemia, hypertension, and renal disease.

Purpose of the Study:

  • To summarize the current understanding of gout's epidemiology and risk factors.
  • To highlight the potential health consequences of gout, including joint and organ damage.
  • To describe the typical clinical progression of gout from asymptomatic hyperuricemia to chronic disease.

Main Methods:

  • Literature review of epidemiological studies on gout.
  • Analysis of risk factors associated with gout development.
  • Description of gout's pathophysiology and clinical manifestations.

Main Results:

  • Gout incidence and prevalence are increasing, especially among the elderly.
  • Hyperuricemia, hypertension, renal disease, and dietary factors (high fructose drinks, red meat, organ meats, seafood, alcohol) are linked to increased gout risk.
  • Gout can cause inflammation and damage to joints, cartilage, bone, and organs like the heart and kidneys.

Conclusions:

  • Gout is a growing public health concern, particularly in aging populations.
  • Identifying and managing risk factors is crucial for preventing gout and its complications.
  • Gout can progress from asymptomatic hyperuricemia to debilitating chronic disease with significant morbidity.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...